Skip to main content

Life Sciences

Volume 555: debated on Thursday 20 December 2012

Last week, the Prime Minister launched the “One Year On” report for our life sciences strategy, which included a new commitment to sequence 100,000 genomes. In the autumn statement, the Chancellor announced an additional £100 million for life sciences research and, in the past year, more than £1 billion of private sector investment has been attracted to the UK on the back of Government initiatives for the life sciences. We are therefore succeeding in creating the right environment to attract global life sciences investment.

I welcome the Government’s progress report, “Strategy for UK Life Sciences—One Year On”, and the Minister’s strong support for this vital sector. Given the critical contribution of life sciences and pharmaceuticals to Macclesfield’s local economy, what plans does he have to build on this important momentum in the year ahead?

We need to do more and we can do more. We are going to work closely with British businesses, including AstraZeneca, which I remember visiting with my hon. Friend in his constituency earlier this year. That company has received a conditional offer through round 3 of the regional growth fund. We are continuing to back this very important, internationally competitive industry.